Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
(NASDAQ: ARGX) Delayed: 990.32 -5.45 (0.55%)
Previous Close $995.77    52 Week High $ 
Open $1001.62    52 Week Low $ 
Day High $1003.83    P/E N/A 
Day Low $989.33    EPS $ 
Volume 244,024       

(NASDAQ: ARGX) Delayed: 990.32 -5.45 (0.55%)
Previous Close $995.77    52 Week High $ 
Open $1001.62    52 Week Low $ 
Day High $1003.83    P/E N/A 
Day Low $989.33    EPS $ 
Volume 244,024       

(NASDAQ: ZLAB) Delayed: 25.70 -0.11 (0.43%)
Previous Close $25.81    52 Week High $ 
Open $26.26    52 Week Low $ 
Day High $27.14    P/E N/A 
Day Low $25.60    EPS $ 
Volume 887,484